IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 07 02 2022
accepted: 08 04 2022
revised: 07 04 2022
pubmed: 24 4 2022
medline: 1 11 2022
entrez: 23 4 2022
Statut: ppublish

Résumé

The processes leading from disturbed B-cell development to adult B-cell progenitor acute lymphoblastic leukemia (BCP-ALL) remain poorly understood. Here, we describe Irf4

Identifiants

pubmed: 35459909
doi: 10.1038/s41418-022-01005-z
pii: 10.1038/s41418-022-01005-z
pmc: PMC9613660
doi:

Substances chimiques

Interleukin-7 0
JAK3 protein, human EC 2.7.10.2
Janus Kinase 3 EC 2.7.10.2
interferon regulatory factor-4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2163-2176

Informations de copyright

© 2022. The Author(s).

Références

Arch Histol Cytol. 2003 May;66(2):123-43
pubmed: 12846553
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Immunol. 2015 Jul;16(7):766-774
pubmed: 25985233
Leukemia. 2017 Apr;31(4):981-984
pubmed: 27932787
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
pubmed: 18503082
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):137-145
pubmed: 30504302
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Haematologica. 2017 Jan;102(1):130-138
pubmed: 27561722
J Exp Med. 1991 May 1;173(5):1213-25
pubmed: 1827140
Eur J Immunol. 1989 Jul;19(7):1297-302
pubmed: 2569403
Immunol Rev. 2019 May;289(1):142-157
pubmed: 30977190
Immunity. 2004 Jun;20(6):707-18
pubmed: 15189736
Best Pract Res Clin Haematol. 2019 Dec;32(4):101095
pubmed: 31779973
Leukemia. 2019 Aug;33(8):1895-1909
pubmed: 30842609
J Exp Med. 2005 Feb 21;201(4):637-45
pubmed: 15710654
Nat Rev Immunol. 2005 Feb;5(2):125-35
pubmed: 15688040
Blood. 2010 Feb 4;115(5):1006-17
pubmed: 19965641
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nature. 1990 Aug 2;346(6283):425-34
pubmed: 1974032
Nature. 2002 Jul 4;418(6893):99-103
pubmed: 12097915
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Exp Med. 2017 Mar 6;214(3):793-814
pubmed: 28190001
Blood. 2010 Oct 14;116(15):2759-67
pubmed: 20585039
N Engl J Med. 2012 Mar 1;366(9):799-807
pubmed: 22375971
BMC Bioinformatics. 2021 Dec 23;22(1):610
pubmed: 34949163
Int Immunol. 1998 Jan;10(1):49-59
pubmed: 9488155
Cancer Discov. 2015 Dec;5(12):1328-43
pubmed: 26408659
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Immunity. 1999 Apr;10(4):463-71
pubmed: 10229189
Science. 1997 Jan 24;275(5299):540-3
pubmed: 8999800
Cancer Causes Control. 2015 Nov;26(11):1627-42
pubmed: 26376890
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nucleic Acids Res. 2012 May;40(9):e69
pubmed: 22302147
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Leukemia. 2013 Mar;27(3):541-52
pubmed: 23047478
Int J Mol Sci. 2020 Mar 23;21(6):
pubmed: 32210016
J Exp Med. 2018 Oct 1;215(10):2586-2599
pubmed: 30158115
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8025-30
pubmed: 24843152
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2503-8
pubmed: 22308406
Immunity. 2008 Mar;28(3):335-45
pubmed: 18280186
Eur J Immunol. 2014 Aug;44(8):2306-17
pubmed: 24777940
Methods Enzymol. 2013;533:225-33
pubmed: 24182927
Curr Top Microbiol Immunol. 2013;371:1-27
pubmed: 23686230
Cancers (Basel). 2020 Jul 20;12(7):
pubmed: 32698524
BMC Bioinformatics. 2019 Jun 13;20(1):331
pubmed: 31195976
Blood Adv. 2018 Nov 13;2(21):2798-2810
pubmed: 30355579
Semin Immunol. 2006 Feb;18(1):31-9
pubmed: 16386923
Blood. 2017 Feb 2;129(5):572-581
pubmed: 27919910
EBioMedicine. 2016 Jun;8:173-183
pubmed: 27428428
Eur J Immunol. 2019 May;49(5):812-815
pubmed: 30218581
Leukemia. 2016 Jun;30(6):1375-87
pubmed: 26932576
Eur J Immunol. 2016 Sep;46(9):2155-61
pubmed: 27325567
Nature. 2002 Sep 5;419(6902):43-8
pubmed: 12214226
EMBO J. 1988 May;7(5):1337-43
pubmed: 3261687
Semin Immunol. 2012 Jun;24(3):198-208
pubmed: 22421572
Genes Dev. 2003 Jul 15;17(14):1703-8
pubmed: 12832394
J Immunol. 2012 Aug 15;189(4):1577-84
pubmed: 22786774
Nat Rev Immunol. 2009 Mar;9(3):195-205
pubmed: 19240758
Lancet. 2020 Apr 4;395(10230):1146-1162
pubmed: 32247396
Semin Hematol. 2013 Oct;50(4):314-24
pubmed: 24246699
Eur J Immunol. 2014 Jul;44(7):1886-95
pubmed: 24782159
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766

Auteurs

Dennis Das Gupta (D)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Christoph Paul (C)

University Hospital Gießen and Marburg, Dept. of Ophthalmology, Philipps University Marburg, Marburg, Germany.

Nadine Samel (N)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
MVZ for Laboratory Medicine and Microbiology, Koblenz-Mittelrhein, Germany.

Maria Bieringer (M)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Daniel Staudenraus (D)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Federico Marini (F)

Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Hartmann Raifer (H)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Lisa Menke (L)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Lea Hansal (L)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Bärbel Camara (B)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.

Edith Roth (E)

Division of Molecular Immunology, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Erlangen, Germany.

Patrick Daum (P)

Division of Molecular Immunology, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Erlangen, Germany.

Michael Wanzel (M)

Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.

Marco Mernberger (M)

Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.
Genomics Core Facility, Philipps University Marburg, Marburg, Germany.

Andrea Nist (A)

Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.

Uta-Maria Bauer (UM)

Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.

Frederik Helmprobst (F)

Core Facility for Mouse Pathology and Electron Microscopy, Philipps University Marburg, Marburg, Germany.
University Hospital Gießen and Marburg, and Philipps University, Institute of Neuropathology, Marburg, Germany.

Malte Buchholz (M)

University Hospital Gießen and Marburg, and Philipps University, Clinic for Gastroenterology and Core Facility Small Animal Ultrasound, Marburg, Germany.

Katrin Roth (K)

Core facility for Cellular Imaging, Philipps University Marburg, Marburg, Germany.

Lorenz Bastian (L)

Medical Department II, Hematology and Oncology, University Medical Center Schleswig- Holstein, Kiel, Germany.

Alina M Hartmann (AM)

Medical Department II, Hematology and Oncology, University Medical Center Schleswig- Holstein, Kiel, Germany.

Claudia Baldus (C)

Medical Department II, Hematology and Oncology, University Medical Center Schleswig- Holstein, Kiel, Germany.

Koichi Ikuta (K)

Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.

Andreas Neubauer (A)

University Hospital Gießen and Marburg, and Philipps University, Dept. Hematology, Oncology and Immunology, Marburg, Germany.

Andreas Burchert (A)

University Hospital Gießen and Marburg, and Philipps University, Dept. Hematology, Oncology and Immunology, Marburg, Germany.

Hans-Martin Jäck (HM)

Division of Molecular Immunology, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Erlangen, Germany.

Matthias Klein (M)

Institute for Immunology, Research Center for Immunotherapy (FZI), University Cancer Center, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Tobias Bopp (T)

Institute for Immunology, Research Center for Immunotherapy (FZI), University Cancer Center, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
German Cancer Consortium (DKTK), Mainz, Germany.

Thorsten Stiewe (T)

Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.
Genomics Core Facility, Philipps University Marburg, Marburg, Germany.

Axel Pagenstecher (A)

Core Facility for Mouse Pathology and Electron Microscopy, Philipps University Marburg, Marburg, Germany.
University Hospital Gießen and Marburg, and Philipps University, Institute of Neuropathology, Marburg, Germany.

Michael Lohoff (M)

Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany. lohoff@med.uni-marburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH